Due to their potent anti-inflammatory capacity (particularly in predominantly eosinophilic
inflammation) and immunosuppressive properties, inhaled corticosteroids (ICSs) are widely …

Background Chronic bronchial infection is frequent in chronic obstructive pulmonary disease
(COPD), but the impact of the isolation of pathogenic bacteria, and in particular …

Two 2D luminous zinc (II) coordination polymers have been synthesized hydrothermally with
the formulas of [Zn (4-HDBB)(3-bibz)](1) and [Zn 2 (4-DBB)(OH)(4, 4′-bbpy) 1.5]· 2H 2 O …

Lower respiratory tract infections (LRTIs) are inherited disorders which often causes chronic
respiratory infections for which patients repeatedly receive oral antibiotics, particularly …

Up to 50% of patients with chronic obstructive pulmonary disease (COPD) in stable state
may carry potentially pathogenic microorganisms (PPMs) in their airways. The presence of …

Both chronic obstructive pulmonary disease and bronchiectasis are highly prevalent
diseases. In both cases, inhaled corticosteroids (ICs) are associated with a decrease in …

According to the Global Burden of Disease (GBD) study, chronic obstructive pulmonary
disease (COPD) has become the third leading cause of death all over the world. The high …

Inhaled bronchodilator therapy with long-acting muscarinic antagonists (LAMAs) and long-
acting β2-agonists (LABAs) in combination is currently the mainstay of treatment for chronic …

The use of inhaled antibiotics was initially almost exclusively confined to patients with cystic
fibrosis (CF). However, it has been extended in recent decades to patients with non-CF …

International guidelines on the treatment of bronchiectasis indicate that the use of inhaled
antibiotics is effective, especially in symptomatic chronic bronchial infection (CBI) due to …